"Antiviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
| Descriptor ID |
D000998
|
| MeSH Number(s) |
D27.505.954.122.388
|
| Concept/Terms |
Antiviral Agents- Antiviral Agents
- Agents, Antiviral
- Antivirals
- Antiviral Drugs
- Drugs, Antiviral
|
Below are MeSH descriptors whose meaning is more general than "Antiviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Antiviral Agents".
This graph shows the total number of publications written about "Antiviral Agents" by people in this website by year, and whether "Antiviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 3 | 0 | 3 |
| 1994 | 1 | 2 | 3 |
| 1995 | 9 | 2 | 11 |
| 1996 | 10 | 3 | 13 |
| 1997 | 8 | 4 | 12 |
| 1998 | 9 | 2 | 11 |
| 1999 | 9 | 4 | 13 |
| 2000 | 2 | 3 | 5 |
| 2001 | 7 | 5 | 12 |
| 2002 | 8 | 6 | 14 |
| 2003 | 6 | 7 | 13 |
| 2004 | 8 | 3 | 11 |
| 2005 | 6 | 4 | 10 |
| 2006 | 14 | 5 | 19 |
| 2007 | 12 | 7 | 19 |
| 2008 | 5 | 5 | 10 |
| 2009 | 6 | 6 | 12 |
| 2010 | 10 | 3 | 13 |
| 2011 | 17 | 6 | 23 |
| 2012 | 8 | 3 | 11 |
| 2013 | 9 | 4 | 13 |
| 2014 | 20 | 1 | 21 |
| 2015 | 21 | 4 | 25 |
| 2016 | 15 | 1 | 16 |
| 2017 | 9 | 6 | 15 |
| 2018 | 5 | 3 | 8 |
| 2019 | 9 | 6 | 15 |
| 2020 | 8 | 8 | 16 |
| 2021 | 10 | 10 | 20 |
| 2022 | 1 | 4 | 5 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antiviral Agents" by people in Profiles.
-
Prolonged Interferon-Stimulated Gene and Protein Signatures in Multiple Sclerosis Induced by PEGylated IFN-?-1a Compared to Non-PEGylated IFN-?-1a. J Interferon Cytokine Res. 2023 03; 43(3):108-120.
-
Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma. Cancer. 2022 10 01; 128(19):3470-3478.
-
Zoster Eye Disease Study: Rationale and Design. Cornea. 2022 May 01; 41(5):562-571.
-
Viral hepatitis: Past, present, and future. World J Gastroenterol. 2022 Apr 14; 28(14):1405-1429.
-
Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago. PLoS One. 2022; 17(3):e0264983.
-
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses. Sci Adv. 2022 Feb 25; 8(8):eabi6110.
-
Myeloid cell interferon responses correlate with clearance of SARS-CoV-2. Nat Commun. 2022 02 03; 13(1):679.
-
Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk? Clin Infect Dis. 2021 12 06; 73(11):e3990-e3995.
-
Stress-Induced Epstein-Barr Virus Reactivation. Biomolecules. 2021 09 18; 11(9).
-
Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach. Bioorg Med Chem. 2021 10 01; 47:116393.